Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: Q4Q9A1
Term | Name | Level | Count |
---|---|---|---|
GO:0000723 | telomere maintenance | 5 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006259 | DNA metabolic process | 4 | 1 |
GO:0006281 | DNA repair | 5 | 1 |
GO:0006310 | DNA recombination | 5 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0006950 | response to stress | 2 | 1 |
GO:0006974 | DNA damage response | 4 | 1 |
GO:0006996 | organelle organization | 4 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0032200 | telomere organization | 6 | 1 |
GO:0033554 | cellular response to stress | 3 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0050896 | response to stimulus | 1 | 1 |
GO:0051276 | chromosome organization | 5 | 1 |
GO:0051716 | cellular response to stimulus | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 1 |
GO:0003678 | DNA helicase activity | 3 | 1 |
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004386 | helicase activity | 2 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0005524 | ATP binding | 5 | 1 |
GO:0008094 | ATP-dependent activity, acting on DNA | 2 | 1 |
GO:0016462 | pyrophosphatase activity | 5 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 1 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 1 |
GO:0016887 | ATP hydrolysis activity | 7 | 1 |
GO:0017076 | purine nucleotide binding | 4 | 1 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 6 | 1 |
GO:0030554 | adenyl nucleotide binding | 5 | 1 |
GO:0032553 | ribonucleotide binding | 3 | 1 |
GO:0032555 | purine ribonucleotide binding | 4 | 1 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 1 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 1 |
GO:0036094 | small molecule binding | 2 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043168 | anion binding | 3 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:0097367 | carbohydrate derivative binding | 2 | 1 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
GO:0140657 | ATP-dependent activity | 1 | 1 |
GO:1901265 | nucleoside phosphate binding | 3 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 310 | 314 | PF00656 | 0.757 |
CLV_MEL_PAP_1 | 101 | 107 | PF00089 | 0.592 |
CLV_NRD_NRD_1 | 165 | 167 | PF00675 | 0.473 |
CLV_NRD_NRD_1 | 217 | 219 | PF00675 | 0.456 |
CLV_NRD_NRD_1 | 229 | 231 | PF00675 | 0.469 |
CLV_NRD_NRD_1 | 27 | 29 | PF00675 | 0.598 |
CLV_NRD_NRD_1 | 486 | 488 | PF00675 | 0.650 |
CLV_NRD_NRD_1 | 509 | 511 | PF00675 | 0.553 |
CLV_PCSK_KEX2_1 | 165 | 167 | PF00082 | 0.473 |
CLV_PCSK_KEX2_1 | 229 | 231 | PF00082 | 0.519 |
CLV_PCSK_KEX2_1 | 27 | 29 | PF00082 | 0.598 |
CLV_PCSK_KEX2_1 | 384 | 386 | PF00082 | 0.570 |
CLV_PCSK_KEX2_1 | 488 | 490 | PF00082 | 0.641 |
CLV_PCSK_KEX2_1 | 509 | 511 | PF00082 | 0.553 |
CLV_PCSK_KEX2_1 | 667 | 669 | PF00082 | 0.534 |
CLV_PCSK_PC1ET2_1 | 384 | 386 | PF00082 | 0.570 |
CLV_PCSK_PC1ET2_1 | 488 | 490 | PF00082 | 0.641 |
CLV_PCSK_PC1ET2_1 | 667 | 669 | PF00082 | 0.534 |
CLV_PCSK_SKI1_1 | 229 | 233 | PF00082 | 0.457 |
CLV_PCSK_SKI1_1 | 362 | 366 | PF00082 | 0.757 |
CLV_PCSK_SKI1_1 | 381 | 385 | PF00082 | 0.423 |
CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.541 |
DEG_MDM2_SWIB_1 | 581 | 589 | PF02201 | 0.434 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.693 |
DEG_SPOP_SBC_1 | 397 | 401 | PF00917 | 0.614 |
DOC_CKS1_1 | 171 | 176 | PF01111 | 0.575 |
DOC_CYCLIN_RxL_1 | 654 | 662 | PF00134 | 0.502 |
DOC_MAPK_gen_1 | 229 | 236 | PF00069 | 0.542 |
DOC_MAPK_gen_1 | 487 | 495 | PF00069 | 0.599 |
DOC_MAPK_gen_1 | 611 | 620 | PF00069 | 0.665 |
DOC_MAPK_gen_1 | 74 | 81 | PF00069 | 0.479 |
DOC_MAPK_MEF2A_6 | 611 | 620 | PF00069 | 0.527 |
DOC_MAPK_MEF2A_6 | 655 | 663 | PF00069 | 0.487 |
DOC_PP1_RVXF_1 | 622 | 629 | PF00149 | 0.538 |
DOC_PP1_RVXF_1 | 76 | 82 | PF00149 | 0.553 |
DOC_PP2B_LxvP_1 | 240 | 243 | PF13499 | 0.560 |
DOC_USP7_MATH_1 | 271 | 275 | PF00917 | 0.687 |
DOC_USP7_MATH_1 | 303 | 307 | PF00917 | 0.697 |
DOC_USP7_MATH_1 | 354 | 358 | PF00917 | 0.699 |
DOC_USP7_MATH_1 | 577 | 581 | PF00917 | 0.525 |
DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.429 |
DOC_USP7_UBL2_3 | 246 | 250 | PF12436 | 0.512 |
DOC_USP7_UBL2_3 | 555 | 559 | PF12436 | 0.664 |
DOC_WW_Pin1_4 | 170 | 175 | PF00397 | 0.493 |
LIG_14-3-3_CanoR_1 | 229 | 237 | PF00244 | 0.477 |
LIG_14-3-3_CanoR_1 | 260 | 265 | PF00244 | 0.730 |
LIG_14-3-3_CanoR_1 | 533 | 541 | PF00244 | 0.554 |
LIG_14-3-3_CanoR_1 | 635 | 642 | PF00244 | 0.523 |
LIG_APCC_ABBA_1 | 607 | 612 | PF00400 | 0.567 |
LIG_BRCT_BRCA1_1 | 258 | 262 | PF00533 | 0.718 |
LIG_BRCT_BRCA1_1 | 354 | 358 | PF00533 | 0.703 |
LIG_BRCT_BRCA1_1 | 447 | 451 | PF00533 | 0.595 |
LIG_Clathr_ClatBox_1 | 157 | 161 | PF01394 | 0.482 |
LIG_Clathr_ClatBox_1 | 201 | 205 | PF01394 | 0.564 |
LIG_deltaCOP1_diTrp_1 | 205 | 211 | PF00928 | 0.393 |
LIG_deltaCOP1_diTrp_1 | 566 | 575 | PF00928 | 0.580 |
LIG_deltaCOP1_diTrp_1 | 627 | 631 | PF00928 | 0.526 |
LIG_EH1_1 | 390 | 398 | PF00400 | 0.589 |
LIG_FHA_1 | 153 | 159 | PF00498 | 0.510 |
LIG_FHA_1 | 455 | 461 | PF00498 | 0.526 |
LIG_FHA_1 | 512 | 518 | PF00498 | 0.480 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.423 |
LIG_FHA_1 | 599 | 605 | PF00498 | 0.613 |
LIG_FHA_1 | 654 | 660 | PF00498 | 0.482 |
LIG_FHA_2 | 275 | 281 | PF00498 | 0.802 |
LIG_FHA_2 | 320 | 326 | PF00498 | 0.756 |
LIG_FHA_2 | 561 | 567 | PF00498 | 0.533 |
LIG_Integrin_isoDGR_2 | 507 | 509 | PF01839 | 0.571 |
LIG_LIR_Apic_2 | 185 | 190 | PF02991 | 0.444 |
LIG_LIR_Apic_2 | 427 | 432 | PF02991 | 0.614 |
LIG_LIR_Gen_1 | 205 | 213 | PF02991 | 0.410 |
LIG_LIR_Gen_1 | 535 | 545 | PF02991 | 0.507 |
LIG_LIR_Nem_3 | 133 | 138 | PF02991 | 0.323 |
LIG_LIR_Nem_3 | 173 | 178 | PF02991 | 0.394 |
LIG_LIR_Nem_3 | 185 | 189 | PF02991 | 0.425 |
LIG_LIR_Nem_3 | 205 | 210 | PF02991 | 0.399 |
LIG_LIR_Nem_3 | 25 | 29 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 5 | 10 | PF02991 | 0.644 |
LIG_LIR_Nem_3 | 526 | 530 | PF02991 | 0.526 |
LIG_LIR_Nem_3 | 535 | 541 | PF02991 | 0.504 |
LIG_LIR_Nem_3 | 648 | 654 | PF02991 | 0.511 |
LIG_LYPXL_S_1 | 471 | 475 | PF13949 | 0.577 |
LIG_LYPXL_yS_3 | 472 | 475 | PF13949 | 0.539 |
LIG_NRBOX | 516 | 522 | PF00104 | 0.569 |
LIG_PCNA_PIPBox_1 | 3 | 12 | PF02747 | 0.710 |
LIG_PCNA_yPIPBox_3 | 3 | 15 | PF02747 | 0.711 |
LIG_Pex14_1 | 207 | 211 | PF04695 | 0.377 |
LIG_Pex14_2 | 131 | 135 | PF04695 | 0.376 |
LIG_Pex14_2 | 22 | 26 | PF04695 | 0.631 |
LIG_Pex14_2 | 581 | 585 | PF04695 | 0.423 |
LIG_SH2_CRK | 237 | 241 | PF00017 | 0.565 |
LIG_SH2_CRK | 380 | 384 | PF00017 | 0.732 |
LIG_SH2_CRK | 429 | 433 | PF00017 | 0.688 |
LIG_SH2_CRK | 553 | 557 | PF00017 | 0.515 |
LIG_SH2_NCK_1 | 181 | 185 | PF00017 | 0.472 |
LIG_SH2_STAT3 | 200 | 203 | PF00017 | 0.414 |
LIG_SH2_STAT3 | 477 | 480 | PF00017 | 0.580 |
LIG_SH2_STAT5 | 200 | 203 | PF00017 | 0.414 |
LIG_SH2_STAT5 | 95 | 98 | PF00017 | 0.488 |
LIG_SH3_1 | 168 | 174 | PF00018 | 0.555 |
LIG_SH3_2 | 483 | 488 | PF14604 | 0.651 |
LIG_SH3_3 | 168 | 174 | PF00018 | 0.547 |
LIG_SH3_3 | 187 | 193 | PF00018 | 0.321 |
LIG_SH3_3 | 206 | 212 | PF00018 | 0.417 |
LIG_SH3_3 | 309 | 315 | PF00018 | 0.751 |
LIG_SH3_3 | 326 | 332 | PF00018 | 0.782 |
LIG_SH3_3 | 365 | 371 | PF00018 | 0.594 |
LIG_SH3_3 | 455 | 461 | PF00018 | 0.586 |
LIG_SH3_3 | 467 | 473 | PF00018 | 0.557 |
LIG_SH3_3 | 480 | 486 | PF00018 | 0.525 |
LIG_SH3_3 | 542 | 548 | PF00018 | 0.523 |
LIG_SUMO_SIM_anti_2 | 142 | 147 | PF11976 | 0.386 |
LIG_SUMO_SIM_anti_2 | 340 | 352 | PF11976 | 0.749 |
LIG_SUMO_SIM_anti_2 | 603 | 608 | PF11976 | 0.592 |
LIG_SUMO_SIM_par_1 | 142 | 147 | PF11976 | 0.407 |
LIG_SUMO_SIM_par_1 | 154 | 159 | PF11976 | 0.428 |
LIG_SUMO_SIM_par_1 | 600 | 605 | PF11976 | 0.625 |
LIG_TRAF2_1 | 111 | 114 | PF00917 | 0.564 |
LIG_TYR_ITIM | 378 | 383 | PF00017 | 0.745 |
LIG_TYR_ITIM | 551 | 556 | PF00017 | 0.486 |
MOD_CK1_1 | 134 | 140 | PF00069 | 0.410 |
MOD_CK1_1 | 263 | 269 | PF00069 | 0.694 |
MOD_CK1_1 | 274 | 280 | PF00069 | 0.785 |
MOD_CK1_1 | 338 | 344 | PF00069 | 0.696 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.439 |
MOD_CK1_1 | 400 | 406 | PF00069 | 0.637 |
MOD_CK2_1 | 103 | 109 | PF00069 | 0.633 |
MOD_CK2_1 | 249 | 255 | PF00069 | 0.663 |
MOD_CK2_1 | 264 | 270 | PF00069 | 0.417 |
MOD_CK2_1 | 274 | 280 | PF00069 | 0.689 |
MOD_CK2_1 | 560 | 566 | PF00069 | 0.475 |
MOD_CK2_1 | 577 | 583 | PF00069 | 0.510 |
MOD_CMANNOS | 628 | 631 | PF00535 | 0.528 |
MOD_Cter_Amidation | 507 | 510 | PF01082 | 0.544 |
MOD_GlcNHglycan | 305 | 308 | PF01048 | 0.664 |
MOD_GlcNHglycan | 343 | 346 | PF01048 | 0.666 |
MOD_GlcNHglycan | 400 | 403 | PF01048 | 0.645 |
MOD_GlcNHglycan | 556 | 559 | PF01048 | 0.562 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.440 |
MOD_GSK3_1 | 126 | 133 | PF00069 | 0.553 |
MOD_GSK3_1 | 152 | 159 | PF00069 | 0.393 |
MOD_GSK3_1 | 256 | 263 | PF00069 | 0.627 |
MOD_GSK3_1 | 272 | 279 | PF00069 | 0.781 |
MOD_GSK3_1 | 334 | 341 | PF00069 | 0.712 |
MOD_GSK3_1 | 354 | 361 | PF00069 | 0.682 |
MOD_GSK3_1 | 396 | 403 | PF00069 | 0.616 |
MOD_GSK3_1 | 528 | 535 | PF00069 | 0.554 |
MOD_GSK3_1 | 584 | 591 | PF00069 | 0.425 |
MOD_GSK3_1 | 672 | 679 | PF00069 | 0.727 |
MOD_N-GLC_1 | 533 | 538 | PF02516 | 0.604 |
MOD_N-GLC_1 | 598 | 603 | PF02516 | 0.642 |
MOD_NEK2_1 | 126 | 131 | PF00069 | 0.477 |
MOD_NEK2_1 | 2 | 7 | PF00069 | 0.631 |
MOD_NEK2_1 | 217 | 222 | PF00069 | 0.554 |
MOD_NEK2_1 | 262 | 267 | PF00069 | 0.692 |
MOD_NEK2_1 | 339 | 344 | PF00069 | 0.754 |
MOD_NEK2_1 | 358 | 363 | PF00069 | 0.653 |
MOD_NEK2_1 | 396 | 401 | PF00069 | 0.512 |
MOD_NEK2_1 | 407 | 412 | PF00069 | 0.520 |
MOD_NEK2_2 | 577 | 582 | PF00069 | 0.526 |
MOD_NEK2_2 | 588 | 593 | PF00069 | 0.516 |
MOD_PIKK_1 | 109 | 115 | PF00454 | 0.545 |
MOD_PIKK_1 | 34 | 40 | PF00454 | 0.455 |
MOD_PKA_1 | 229 | 235 | PF00069 | 0.497 |
MOD_PKA_2 | 103 | 109 | PF00069 | 0.617 |
MOD_PKA_2 | 217 | 223 | PF00069 | 0.476 |
MOD_PKA_2 | 229 | 235 | PF00069 | 0.468 |
MOD_PKA_2 | 532 | 538 | PF00069 | 0.580 |
MOD_PKA_2 | 634 | 640 | PF00069 | 0.541 |
MOD_Plk_1 | 127 | 133 | PF00069 | 0.485 |
MOD_Plk_1 | 598 | 604 | PF00069 | 0.619 |
MOD_Plk_2-3 | 249 | 255 | PF00069 | 0.649 |
MOD_Plk_2-3 | 409 | 415 | PF00069 | 0.643 |
MOD_Plk_2-3 | 454 | 460 | PF00069 | 0.652 |
MOD_Plk_4 | 152 | 158 | PF00069 | 0.407 |
MOD_Plk_4 | 212 | 218 | PF00069 | 0.488 |
MOD_Plk_4 | 354 | 360 | PF00069 | 0.720 |
MOD_Plk_4 | 577 | 583 | PF00069 | 0.448 |
MOD_ProDKin_1 | 170 | 176 | PF00069 | 0.484 |
TRG_DiLeu_BaEn_2 | 386 | 392 | PF01217 | 0.620 |
TRG_DiLeu_BaEn_4 | 226 | 232 | PF01217 | 0.348 |
TRG_ENDOCYTIC_2 | 237 | 240 | PF00928 | 0.490 |
TRG_ENDOCYTIC_2 | 380 | 383 | PF00928 | 0.737 |
TRG_ENDOCYTIC_2 | 468 | 471 | PF00928 | 0.553 |
TRG_ENDOCYTIC_2 | 472 | 475 | PF00928 | 0.532 |
TRG_ENDOCYTIC_2 | 553 | 556 | PF00928 | 0.497 |
TRG_ER_diArg_1 | 165 | 168 | PF00400 | 0.433 |
TRG_ER_diArg_1 | 228 | 230 | PF00400 | 0.544 |
TRG_ER_diArg_1 | 26 | 28 | PF00400 | 0.620 |
TRG_ER_diArg_1 | 461 | 464 | PF00400 | 0.555 |
TRG_ER_diArg_1 | 486 | 489 | PF00400 | 0.609 |
TRG_ER_diArg_1 | 509 | 511 | PF00400 | 0.571 |
TRG_ER_diArg_1 | 654 | 657 | PF00400 | 0.475 |
TRG_NES_CRM1_1 | 114 | 128 | PF08389 | 0.564 |
TRG_NES_CRM1_1 | 244 | 255 | PF08389 | 0.550 |
TRG_NES_CRM1_1 | 409 | 424 | PF08389 | 0.544 |
TRG_NLS_MonoExtN_4 | 486 | 491 | PF00514 | 0.633 |
TRG_Pf-PMV_PEXEL_1 | 165 | 170 | PF00026 | 0.544 |
TRG_Pf-PMV_PEXEL_1 | 229 | 233 | PF00026 | 0.573 |
TRG_Pf-PMV_PEXEL_1 | 657 | 662 | PF00026 | 0.476 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I7F1 | Leptomonas seymouri | 68% | 99% |
A0A0S4IRV6 | Bodo saltans | 42% | 99% |
A0A1X0NSL8 | Trypanosomatidae | 52% | 94% |
A0A3S7WZQ1 | Leishmania donovani | 96% | 100% |
A0A422MXA7 | Trypanosoma rangeli | 53% | 95% |
A4HEU8 | Leishmania braziliensis | 88% | 100% |
A4I222 | Leishmania infantum | 97% | 100% |
C9ZRY5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 99% |
E9AY71 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q57VU6 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | 52% | 99% |
V5DR06 | Trypanosoma cruzi | 52% | 95% |